Genentech 4Q Revenues: $1.9 billion (+44%) 4Q Earnings: $339.2 million (+64%) FY Revenues: $6.6 billion (+44%) FY Earnings: $1.3 billion (+63%) Comments: Product sales were up 45% in 2005 to $5.2 million. Sales for the quarter increased 47% to $1.5 million. Rituxan sales were up 16% for the year to $1.8 million and sales for the quarter were up 13% to $484.4 million. Sales of Avastin increased 108% for the year to $1.1 billion and sales increased 89% to $359.1 million f...